The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Imaging in Hepatocellular Carcinoma: What's New?
Semin Ultrasound CT MR. 2023 Jun;44(3):145-161. doi: 10.1053/j.sult.2023.03.002.Epub 2023 Mar 12.
1Department of Emergency Radiology, University Hospital Careggi, Florence, Italy. Electronic address: grazzini.giulia@gmail.com.
2Department of Emergency Radiology, University Hospital Careggi, Florence, Italy.
Abstract
Hepatocellular carcinoma (HCC) is the most common liver cancer and is one of the uppermost 2 causes of cancer death. About 70%-90% of HCCs develop within a cirrhotic liver. According to the most recent guidelines, the imaging characteristics of HCC on contrast-enhanced Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) are generally satisfactory to make a diagnosis. Recently, new advanced techniques such as contrast-enhanced ultrasound, CT perfusion, Dynamic Contrast-enhanced MRI, diffusion weighted imaging and radiomics have increased the diagnostic accuracy and characterization of HCC. This review illustrates the state of the art and recent advances in non-invasive imaging evaluation of HCC.
Stay Informed!
